Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001746473-25-000015

Chief Business Officer acquired 40,150 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hull Hans Chief Business Officer 2025-01-23 Grant or award +40,150 251,708 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hull Hans Chief Business Officer 2025-01-23 Grant or award · Stock Option (Right to Buy) +80,300 80,300 D: show line 2 in the form
Loading xslF345X05/wk-form4_1738019230.xml…